Healthcare Global Enterprises Limited has informed the Exchange about the Letter of Offer dated February 24, 2026 for Rights Issue of fully paid-up equity shares

Capital Market Events View source PDF Explain this filing

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹582.10

prior close

₹583.00

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+0.2%-0.3% vs market

Hospital peers, median of 22sector+0.5%-0.7% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.7 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.5

10m

-1.8

15m

-1.9

30m

-1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.2+0.2-0.3+0.5-0.7

Next day

-1.4+0.4-1.8+0.7-2.1

-1.0-0.6-0.4+1.3-2.3

-1.4-2.8+1.5-1.7+0.3

-5.5-5.4-0.1-3.4-2.2

-7.5-4.4-3.0-1.3-6.2

-3.5-7.1+3.6-3.4-0.1

15d

-5.8-7.8+2.0-7.7+1.9

-7.4-6.6-0.8-7.1-0.3

-0.4+7.7-8.1+3.8-4.2

+13.0+10.3+2.8+8.8+4.3

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Healthcare Global Enterprises (HCG), a cancer care hospital chain, has filed the Letter of Offer for a rights issue of up to 82,94,566 fully paid-up equity shares at ₹512 per share (including a ₹502 premium), aggregating up to ₹424.68 crores. The issue is being offered in the ratio of 1 rights share for every 17 equity shares held on the record date of March 2, 2026. The issue opens on March 11, 2026 and closes on March 25, 2026, with listing expected on or about April 1, 2026. KFin Technologies is the registrar and CARE Ratings is the monitoring agency. Promoters include Hector Asia Holdings II Pte. Ltd., Catalyst Trusteeship Limited, and Dr. B.S. Ajaikumar.

Likely market impact

Eligible shareholders as of March 2, 2026 can subscribe to the rights shares at ₹512 each; existing shareholders who do not exercise their entitlements may see a marginal dilution in their stake. The funds raised will be used as per the objects of the issue disclosed in the Letter of Offer.